Bronstein, Gewirtz & Grossman, LLC introduces an investigation into allegations against Corcept Therapeutics Incorporated (CORT) and encourages investors to turn

New York City, NY / Access Newswire / February 27, 2025 / Bronstein, Gewirtz & Grossman, LLC examines potential claims in the name of buyers of Corcept Therapeutics Incorporated (“Corcept” or “The Company”) (Nasdaq: Cort). Investors who have bought Corcept securities are encouraged to receive additional information and support the examination by visiting the company's website: bgandg..com/cort.

Investigative details

In August 2020, Teva Pharmaceutical Industries Limited (“Teva”) received a permit from the US Food and Drug Administration to market a non-patent version of Korlym, a best-selling Corcept product. On February 20, 2025, the search for Alpha reported that a group of health insurers had filed a lawsuit against Corcept in California and accused Corcept of manipulating the patent process in his efforts, “energetically enforcing” its intellectual ownership rights in connection with the start of the generic product from Teva. In the lawsuit of the lawsuit, Corcept's share price fell by $ 8.44 per share or 11.48%to $ 65.09 per share on February 20, 2025.

What's next?

If you have information about facts about this investigation or bought Corcept Securities, you can support this examination by visiting the company's website: bgandg..com/cort. You can also contact Peretz Bronstein or his customer relationship manager Nathan Miller from Bronstein, Gewirtz & Grossman, LLC: 332-239-2660

There are no costs for you

We represent investors in collective lawsuits on a eventual fee. This means that we will ask the court to refund ourselves for expenses and legal fees, usually a percentage of the entire recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized company that represents investors in collecting lawsuits for securities fraud and shareholder derivative lawsuits. Our company has recovered hundreds of million dollars for investors nationwide.

Follow us to updates to updates too LinkedInPresent XPresent Facebookor Instagram.

Lawyer advertising. Earlier results do not guarantee similar results.

contact

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Nathan Miller
332-239-2660 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC

See the original press release on Access Newswire